| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $268.1M | — | +9.7% |
| Cost of Revenue | $24.8M | — | +21.6% |
| R&D Expense | $76.9M | — | -1.8% |
| SG&A Expense | $171.0M | — | +35.3% |
| Operating Income | -$4.6M | — | -123.9% |
| Pre-tax Income | $4.0M | — | -85.7% |
| Income Tax | $344K | — | -96.1% |
| Net Income | $3.6M | — | -80.8% |
| EPS (Basic) | $0.02 | — | -81.8% |
| EPS (Diluted) | $0.02 | — | -81.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $282.2M | +58.8% | +29.6% |
| Accounts Receivable | $135.3M | +11.4% | +28.0% |
| Inventory | $112.3M | +0.8% | +9.1% |
| Current Assets | $1.10B | +3.2% | +25.8% |
| Total Assets | $1.61B | +2.6% | +41.8% |
| Current Liabilities | $305.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $34.0M | — | +67.2% |
| Capital Expenditures | $5.2M | — | — |
| Investing Cash Flow | $66.3M | — | +153.4% |
| Financing Cash Flow | $4.2M | — | +130.2% |
| Free Cash Flow | $28.8M | — | +41.6% |
| +1.0% |
| Total Liabilities | $357.2M | +6.0% | -2.7% |
| Stockholders' Equity | $1.25B | +1.7% | +63.1% |